Clinical Trial Update: AMES Treatment of the Impaired Leg in Chronic Stroke Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial by AMES Technology evaluating treatment for the impaired leg in chronic stroke patients; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemiparesis
• Stroke

Snippet

Sponsor: AMES Technology | Conditions: Stroke, Cerebrovascular Accident | Phase 1, Phase 2 | Status: UNKNOWN